Market Research Report
Asia-pacific Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||1018666|
|Published||Content info||162 Pages
Delivery time: 2-3 business days
|Asia-pacific Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028|
|Published: July 19, 2021||Content info: 162 Pages||
The Asia-Pacific sleep apnea therapeutics and diagnostics market is anticipated to register a CAGR of 8.35% during the forecast period, 2021-2028. The developing healthcare infrastructure and the rising healthcare expenditure are the dominant growth drivers.
South Korea, Australia & New Zealand, Japan, China, Vietnam, Indonesia, Thailand, India, and Rest of Asia-Pacific are evaluated for the Asia-Pacific sleep apnea therapeutics and diagnostics market growth analysis. In Japan, sleep apnea treatment devices include oral appliances, PAP devices, and adaptive servo ventilators. The usage of alternative therapies is considerably high in the country. According to an NCBI study, the usage of oral appliances was becoming common in patients aged 50 or above as of September 2019. Moreover, the country approved the usage of Inspire therapy, a neurostimulator, for treating sleep apnea.
In Australia & New Zealand, the prevalence of sleep apnea is estimated to be moderately high. The emerging sleep apnea therapeutics and diagnostics market is propelled by technological advancements in sleep apnea platforms and devices. However, the absence of a unified reimbursement policy hinders the market growth.
In South Korea, the expectant increase in the aged population drives market growth, apart from technological advancements. For instance, several local companies like NuEyne and Ybrain are developing wearable devices for sleep apnea treatment. The advancements also entail using piezoelectric sensors for pulse oximetry in sleep apnea patients. Such factors fuel the demand for sleep apnea devices.
Some of the key market players include: Vyaire Medical Inc, Koninklijke Philips NV, Nihon Kohden Corporation, BMC Medical Co Ltd, Teleflex Incorporated, etc.